Source : https://pubmed.ncbi.nlm.nih.gov/42178920/
The participants and researchers collaborated to co-design the study's intervention which included personalised behaviour goals to reduce sedentary behaviour. This working partnership between participants and researchers utilised interviews, diary entries...
Qualitative study found sedentary behavior reduction interventions in COPD promoted improved autonomy, reconnection with meaningful activities, and enhanced self-perception beyond measurable physical activity or exercise-related outcomes.
Source : https://pubmed.ncbi.nlm.nih.gov/42129239/
Renal involvement in sarcoidosis may manifest as hypercalcemia, hypercalciuria, nephrolithiasis, nephrocalcinosis, and other abnormalities, but is often underrecognized. This study investigated chest radiographic findings suggestive of possible sarcoidosis in patients...
Retrospective cohort study found substantial within-individual variability in spirometry measurements, particularly among patients with severe respiratory disease, raising important considerations for COPD diagnosis, monitoring, and treatment decision-making.
Source : https://pubmed.ncbi.nlm.nih.gov/42108174/
Respiratory infections are the most important trigger of acute exacerbations of chronic airway diseases. As a prevalent pathogen, the influenza virus accounts for a markedly higher proportion of cases during...
Clinical practice guideline outlines evidence-based influenza prevention and management strategies for adults with chronic airway diseases, emphasizing vaccination, antiviral treatment, exacerbation prevention, and rational glucocorticoid and antibacterial use.
Source : https://pubmed.ncbi.nlm.nih.gov/42028872/
These findings suggest that the implementation of CEX-HScore may enhance the coding accuracy of COPD exacerbations in newly diagnosed patients. Further data points are needed to robustly evaluate its long-term...
A COPD prediction algorithm improved exacerbation coding accuracy in newly diagnosed patients but did not significantly impact referral rates or overall exacerbation detection, highlighting early benefits and need for longer-term evaluation.
In moderate-to-severe COPD, 12-week tiotropium/olodaterol therapy improved FEV1 and reduced hyperinflation. Cardiac index increased and autonomic function improved, suggesting reduced cardiovascular risk alongside better respiratory outcomes.